InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,283.60
(
-0.64%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.97
(
-0.05%
)
Bitcoin
64,736.67
(
-0.13%
)
Post# of 34624
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

poods

Send PM Follow Ignore
Followers 1
Posts 114
Boards Moderated 0
Alias Born 12/26/2017

poods

Re: attilathehunt post# 27655

Sunday, 07/21/2019 5:57:19 PM

Sunday, July 21, 2019 5:57:19 PM

Post# of 34624
MRKR will likely need to prove efficacy, either with overall survival or a surrogate endpoint (response rate or progression free survival). FDA will likely require a randomized trial, but if they can show enough of a correlation of response with immune markers and improvement on SOC considering toxicity, maybe not. Maybe we'll get some guidance here tomorrow.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRKR News
More MRKR News
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!